An important Phase 3 trial has shown that a new drug that targets gonorrhea works as well as the last existing antibiotic to treat the sexually transmitted infection, results that could lead to ...
Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...
The meningococcal B vaccine is ineffective in gonorrhea prevention among men who have sex with men (MSM) at high risk of ...
SAN DIEGO, May 12, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for EVO100 for the ...
The incidence of gonorrhea continues to increase in Spain and across Europe, highlighting an urgent need for new prevention strategies, including vaccines, despite recent clinical trial setbacks. In ...
Commonly known as the "clap," gonorrhea is a sexually transmitted disease that can cause infertility in both women and men if left untreated. The bad news is that cases are on the rise: According to ...
Qualitative research was conducted among 21 women with previous experience with EVO100. The study objective was to assess the understandability and importance of questions/instruments used to assess ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results